BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, 30-count tablets Supply Disruption — Actavis Inc (Low Risk — Unlike
BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, 30-count tablets Supply Disruption — Actavis Inc (Low Risk — Unlike is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, 30-count tablets; Manufacturer: Actavi
| Drug name | BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, 30-count tablets |
|---|---|
| Manufacturer | Actavis Inc |
| Recall/Disruption reason | Failed Dissolution Specifications: Dissolution test results at 8 hour time-point were above approved specification limit |
| Risk classification | Low Risk — Unlikely to Cause Adverse Health Effects |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-855-2013 |
| Initiation date | 20130731 |
| Quantity affected | 15,132 bottles |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →